Immediate and delayed VEGF-mediated NO synthesis in endothelial cells:: Role of PI3K, PKC and PLC pathways

被引:132
作者
Gélinas, DS
Bernatchez, PN
Rollin, S
Bazan, NG
Sirois, MG
机构
[1] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada
[2] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada
[3] LSU Hlth Sci Ctr, New Orleans, LA 70112 USA
关键词
NO; VEGF; PAF; eNOS; PKC; PLC; PI3K; PLA(2);
D O I
10.1038/sj.bjp.0704956
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The mechanism(s) by which vascular endothelial growth factor (VEGF) induces endothelial nitric oxide synthase (eNOS) activation remain(s) unclear up to a certain extent. Therefore, we sought to evaluate the contribution of numerous pathways in VEGF-induced nitric oxide (NO) synthesis by measuring cGMP production. In addition, as VEGF induces the synthesis of NO and platelet-activating factor (PAF), we wanted to assess if the induction of PAF and NO is contributing to the synthesis of each other. 2 Herein, we show that a treatment of endothelial cells with a phospholipase C (PLC) inhibitor (U73122), a calmodulin antagonist (W-7) or with intracellular calcium chelators (EGTA/AM, BAPTA/AM) prevented VEGF-mediated eNOS Ser(1117)-phosphorylation and NO synthesis measured by cGMP production. 3 Pretreatment with phosphatidylinositol 3-kinase (PI3K) (Wortmannin, LY294002) or protein kinase C (PKC) (GF109203)(, Ro318220) inhibitors attenuated eNOS Ser(1117)-phosphorylation mediated by VEGF, but did not alter immediate (0 - 10 min) cGMP synthesis induced by VEGF, but abrogated by up to 84% the delayed (10-30 min) cGMP synthesis. 4 Pretreatment with PAF synthesis inhibitors or with PAF receptor antagonists did not abrogate neither eNOS Ser(1177)-phosphorylation nor cGMP synthesis mediated by VEGF. 5 In conclusion, VEGF induces an immediate cGMP synthesis through the PLC-Ca2+/CaM pathway, and that the induction of delayed cGMP synthesis implies Akt and PKC activity.
引用
收藏
页码:1021 / 1030
页数:10
相关论文
共 42 条
[11]   VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells [J].
Feng, YY ;
Venema, VJ ;
Venema, RC ;
Tsai, N ;
Caldwell, RB .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 256 (01) :192-197
[12]  
FERRARA N, 1995, LAB INVEST, V72, P615
[13]   The biology of vascular endothelial growth factor [J].
Ferrara, N ;
DavisSmyth, T .
ENDOCRINE REVIEWS, 1997, 18 (01) :4-25
[14]   Phosphorylation of Thr495 regulates Ca2+/calmodulin-dependent endothelial nitric oxide synthase activity [J].
Fleming, I ;
Fisslthaler, B ;
Dimmeler, S ;
Kemp, BE ;
Busse, R .
CIRCULATION RESEARCH, 2001, 88 (11) :E68-E75
[15]   ANGIOGENIC FACTORS [J].
FOLKMAN, J ;
KLAGSBRUN, M .
SCIENCE, 1987, 235 (4787) :442-447
[16]   WHAT IS THE EVIDENCE THAT TUMORS ARE ANGIOGENESIS DEPENDENT [J].
FOLKMAN, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (01) :4-6
[17]   Regulation of endothelium-derived nitric oxide production by the protein kinase Akt [J].
Fulton, D ;
Gratton, JP ;
McCabe, TJ ;
Fontana, J ;
Fujio, Y ;
Walsh, K ;
Franke, TF ;
Papapetropoulos, A ;
Sessa, WC .
NATURE, 1999, 399 (6736) :597-601
[18]   Cellular regulation of endothelial nitric oxide synthase [J].
Govers, R ;
Rabelink, TJ .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2001, 280 (02) :F193-F206
[19]   Reconstitution of an endothelial nitric-oxide synthase (eNOS), hsp90, and caveolin-1 complex in vitro -: Evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1 [J].
Gratton, JP ;
Fontana, J ;
O'Connor, DS ;
García-Cardeña, G ;
McCabe, TJ ;
Sessa, WC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (29) :22268-22272
[20]   Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through Flk-1/KDR activation of c-Src [J].
He, H ;
Venema, VJ ;
Guo, XL ;
Venema, RC ;
Marrero, MB ;
Caldwell, RB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (35) :25130-25135